Third Quarter 2007: Rwanda and Canada Leading the Implementation of the August 2003 Decision for Import/Export of Pharmaceuticals Produced under Compulsory License

Report an error

Summary

AI-generated

This summary is written by a language model reading the source document. It is not the publisher's words and is not a substitute for the original.

Learn more about AI enrichment

The document examines the first practical application of the August 2003 Decision under the WTO's Doha Declaration, where Rwanda notified its intent to import pharmaceutical products from a generic manufacturer in Canada. It highlights that as a Least-Developed Country (LDC), Rwanda is exempt from certain notification requirements under paragraph 1(b) of the Decision. The author argues that this specific case serves as a critical precedent for the future utility and functionality of the system designed to allow countries to access medicines during public health crises via compulsory licensing.

Key insights

AI-generated

These insights are written by a language model reading the source document. They are not the publisher's words and are not a substitute for the original.

Learn more about AI enrichment
  • The Doha Declaration on the TRIPS Agreement and Public Health established that countries have the freedom to define the grounds for granting compulsory licenses and determined that a public health crisis constitutes a national emergency.

Cite the original document

APA
Center for International Environmental Law (2007). Third Quarter 2007: Rwanda and Canada Leading the Implementation of the August 2003 Decision for Import/Export of Pharmaceuticals Produced under Compulsory License. https://www.ciel.org/reports/third-quarter-2007-rwanda-and-canada-leading-the-implementation-of-the-august-2003-decision-for-importexport-of-pharmaceuticals-produced-under-compulsory-license-2/
Chicago
Center for International Environmental Law. Third Quarter 2007: Rwanda and Canada Leading the Implementation of the August 2003 Decision for Import/Export of Pharmaceuticals Produced under Compulsory License. 2007. https://www.ciel.org/reports/third-quarter-2007-rwanda-and-canada-leading-the-implementation-of-the-august-2003-decision-for-importexport-of-pharmaceuticals-produced-under-compulsory-license-2/.
Wikipedia
{{cite report |author=Center for International Environmental Law |title=Third Quarter 2007: Rwanda and Canada Leading the Implementation of the August 2003 Decision for Import/Export of Pharmaceuticals Produced under Compulsory License |date=1 September 2007 |url=https://www.ciel.org/reports/third-quarter-2007-rwanda-and-canada-leading-the-implementation-of-the-august-2003-decision-for-importexport-of-pharmaceuticals-produced-under-compulsory-license-2/ |access-date=17 August 2026 |via=Climate Insights Directory}}
BibTeX
@techreport{centerforinternationalenvironmentallaw2007third, author = {{Center for International Environmental Law}}, title = {{Third Quarter 2007: Rwanda and Canada Leading the Implementation of the August 2003 Decision for Import/Export of Pharmaceuticals Produced under Compulsory License}}, institution = {Center for International Environmental Law}, year = {2007}, month = sep, url = {https://www.ciel.org/reports/third-quarter-2007-rwanda-and-canada-leading-the-implementation-of-the-august-2003-decision-for-importexport-of-pharmaceuticals-produced-under-compulsory-license-2/}, urldate = {2026-08-17}, note = {Indexed by Climate Insights Directory} }

Full text

Collected · Record updated